Title: The Assessment of CA125 Determination for Ovarian Cancer Diagnosis and Prognosis
Abstract: To study the clinical significance of serum CA125 in patients with ovarian cancer, the serum CA125 levels in 100 patients with gynecologic disease before and after treatment were examined by the method of enzyme linked immunosorbent assay(ELISA). With the positive standard of serum CA125 level 35kU/L, the positive rates of ovarian cancer, hysteromyoma, benign teratoma and other benign gynecologic disease were 95%(19/20), 16.7%(6/36), 20%(3/15) and 13.8%(4/29) respectively. But serum CA125 level 65kU/L, there was no positive rates except ovarian cancer group. Of the 20 ovarian cancer patients studied, serum CA125 level in 16 cases decreased significantly (35kU/L) after chemical and surgical therapy. Serum CA125 is useful in the diagnosis and evaluation of treatment and prognosis for ovarian cancer.
Publication Year: 2001
Publication Date: 2001-01-01
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot